Position in JNJ
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$217,070,786
+$29,889,892 QoQ
Shares Held
888,033
-1.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
1.62%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. JNJ ranks #1 (30.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
226,056 | $13,710,296 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $217,070,786 | 888,033 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $187,180,894 | 904,474 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $69,229,894 | 373,368 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $52,684,849 | 344,909 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $55,360,874 | 333,821 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $42,720,169 | 295,396 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $45,496,238 | 280,737 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $39,246,883 | 268,520 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $38,094,683 | 240,816 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $38,649,419 | 246,583 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $38,129,624 | 244,813 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $40,002,046 | 241,675 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $36,877,445 | 237,919 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $40,741,319 | 230,633 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $31,980,007 | 195,764 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $35,363,187 | 199,218 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $26,606,476 | 150,124 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $25,467,019 | 148,869 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $12,803,558 | 79,279 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $13,842,278 | 84,025 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $32,044,963 | 194,980 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $11,407,374 | 72,483 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $17,367,000 | 116,651 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $15,635,805 | 111,184 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $10,956,173 | 83,552 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||